Want to join the conversation?
$MNK said that total company adjusted gross profit as a percentage of net sales fell slightly less than anticipated, hurt by tough comparables and specialty generics. R&D spending in 3Q16 was up YoverY at 7.8% of net sales overall. $MNK added it continues to be focused on accelerating investments in key opportunities in 4Q16 and beyond.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?